Semi-Annual Consolidated Statement Of Income

D.Western Therapeutics Institute, Inc. - Filing #7338952

Concept 2024-01-01 to
2024-03-31
2023-01-01 to
2023-03-31
Semi-annual consolidated statement of income
Statement of income
Net sales
104,819,000 JPY
90,000,000 JPY
Cost of sales
9,128,000 JPY
7,331,000 JPY
Ordinary profit (loss)
-320,454,000 JPY
-101,330,000 JPY
Gross profit (loss)
95,690,000 JPY
82,668,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
414,485,000 JPY
183,753,000 JPY
Operating profit (loss)
-318,795,000 JPY
-101,085,000 JPY
Profit (loss) before income taxes
-320,454,000 JPY
-101,330,000 JPY
Non-operating income
Interest income
4,000 JPY
6,000 JPY
Non-operating income
2,664,000 JPY
1,219,000 JPY
Income taxes - current
398,000 JPY
398,000 JPY
Non-operating expenses
Interest expenses
869,000 JPY
626,000 JPY
Non-operating expenses
4,323,000 JPY
1,464,000 JPY
Income taxes
398,000 JPY
398,000 JPY
Profit (loss)
-320,853,000 JPY
-101,729,000 JPY
Profit (loss) attributable to non-controlling interests
JPY
-3,867,000 JPY
Profit (loss) attributable to owners of parent
-320,853,000 JPY
-97,861,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
-106,000 JPY
94,000 JPY
Other comprehensive income
-106,000 JPY
94,000 JPY
Comprehensive income
-320,959,000 JPY
-101,634,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-320,959,000 JPY
-97,766,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
-3,867,000 JPY
Profit attributable to

Talk to a Data Expert

Have a question? We'll get back to you promptly.